Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C

(2016) Seiichi Tawara et al.   PLoS One

Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C

(2015) K. Ura et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Wisteria floribundaagglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

(2015) Nobuharu Tamaki et al.   HEPATOLOGY RESEARCH

Impact of serum glycosylatedWisteria floribundaagglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis

(2015) Tatsunori Hanai et al.   HEPATOLOGY RESEARCH

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

(2015) Masato Fujiyoshi et al.   JOURNAL OF GASTROENTEROLOGY

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response

(2015) Ryu Sasaki et al.   PLoS One

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

(2013) Yasuhiro Asahina et al.   HEPATOLOGY

Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling

(2013) Atsushi Kuno et al.   Proteomics Clinical Applications

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

(2012) Khayriyyah Mohd Hanafiah et al.   HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Functional Screen for Secreted Proteins by Monoclonal Antibody Library and Identification of Mac-2 Binding Protein (Mac-2BP) as a Potential Therapeutic Target and Biomarker for Lung Cancer

(2012) Lichao Sun et al.   MOLECULAR & CELLULAR PROTEOMICS

Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells

(2012) Venktesh S. Shirure et al.   PLoS One

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

(2010) Yasuhiro Asahina et al.   HEPATOLOGY

The HCV serum proteome: a search for fibrosis protein markers

(2009) K. J. Cheung et al.   JOURNAL OF VIRAL HEPATITIS